Category

Medical Research & Innovations

52 articles

Articles Showing 1–10 of 52

Scientists found that women’s higher dementia rates aren’t just because they live longer, in data from 22 studies across 18 countries

Medical Research & Innovations

Scientists found that women’s higher dementia rates aren’t just because they live longer, in data from 22 studies across 18 countries

Oct 21 · 3 min read · JAMA Neurology

A study of 4,523 people with dementia found that those who were overweight or obese at diagnosis had a lower risk of dying than people of normal weight. The usual statistical explanations for this paradox did not hold up.

Medical Research & Innovations

A study of 4,523 people with dementia found that those who were overweight or obese at diagnosis had a lower risk of dying than people of normal weight. The usual statistical explanations for this paradox did not hold up.

Oct 10 · 4 min read · Journal of Alzheimer’s Disease

A review of 265,000 people found cannabis use was linked to about twice the odds of committing violence in the general population and about 2.5 times among psychiatric patients.

Medical Research & Innovations

A review of 265,000 people found cannabis use was linked to about twice the odds of committing violence in the general population and about 2.5 times among psychiatric patients.

Oct 1 · 4 min read · Institute of Psychiatry, Psychology and Neuroscience

New research found that across 2.3 million older adults, one drug’s side effects were routinely being mistaken for a new disease and treated with another drug. This happened across 24 of the most common medication combinations.

Medical Research & Innovations

New research found that across 2.3 million older adults, one drug’s side effects were routinely being mistaken for a new disease and treated with another drug. This happened across 24 of the most common medication combinations.

Sep 18 · 9 min read · BMJ

A study of 421,402 people found that those taking cholesterol-lowering statins were 15% less likely to develop glaucoma. Among people who already had it, the bigger difference was in who needed surgery.

Medical Research & Innovations

A study of 421,402 people found that those taking cholesterol-lowering statins were 15% less likely to develop glaucoma. Among people who already had it, the bigger difference was in who needed surgery.

Oct 16 · 4 min read · British Journal of Ophthalmology

Scientists found that women who had postpartum depression developed heart disease and stroke at a 56% higher rate, and standard risk calculators leave it out

Medical Research & Innovations

Scientists found that women who had postpartum depression developed heart disease and stroke at a 56% higher rate, and standard risk calculators leave it out

Oct 7 · 6 min read · BMJ Medicine

A study of 333,000 people found that stopping Ozempic erases its cardiovascular benefits far faster than anyone expected. Two years off the drug raises heart risk by 22%.

Medical Research & Innovations

A study of 333,000 people found that stopping Ozempic erases its cardiovascular benefits far faster than anyone expected. Two years off the drug raises heart risk by 22%.

Sep 24 · 9 min read · BMJ Medicine

Scientists found that both unusually low and unusually high hemoglobin on a routine blood test were linked to higher dementia risk over the next 15 years

Medical Research & Innovations

Scientists found that both unusually low and unusually high hemoglobin on a routine blood test were linked to higher dementia risk over the next 15 years

Oct 11 · 4 min read · Journal of Alzheimer's Disease

For a decade, doctors were told Prozac clearly helps depressed kids, but scientists traced that claim to one tiny study with numbers that don’t add up

Medical Research & Innovations

For a decade, doctors were told Prozac clearly helps depressed kids, but scientists traced that claim to one tiny study with numbers that don’t add up

Oct 5 · 6 min read · The Lancet

A new clinical trial gave people psilocin directly, the compound that psilocybin becomes in the body, for the first time since 1960. It was better tolerated, had fewer side effects, and lasted less time.

Medical Research & Innovations

A new clinical trial gave people psilocin directly, the compound that psilocybin becomes in the body, for the first time since 1960. It was better tolerated, had fewer side effects, and lasted less time.

Sep 21 · 9 min read · Journal of Psychopharmacology

Page 1 of 6